Meropenem Dosing for Pediatric Critical Care Patients: Multisite Pharmacokinetic Study, 2012–2020
Authors:
- Anh Thi Van NguyenANAnh Thi Van Nguyen
- Evelyn DhontEDEvelyn Dhont
- Zhiyuan TanZTZhiyuan Tan
- Tatjana Van Der HeggenTHTatjana Van Der Heggen
- Emma BeelEBEmma Beel
- Nick VerougstraeteNVNick Verougstraete
- Veronique StoveVSVeronique Stove
- Pieter-Jan De SutterPSPieter-Jan De Sutter
- Sophie VanhaesebrouckSVSophie Vanhaesebrouck
- Daphné Vania VensDVDaphné Vania Vens
- An VermeulenAVAn Vermeulen
- Peter De PaepePPPeter De Paepe
- 23 September 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 27 (11) , 1445-1454
Abstract
OBJECTIVES: Critically ill children may present with altered pharmacokinetics (PK) and/or pharmacodynamics (PD), leading to suboptimal dosing of meropenem. We aimed to: 1) investigate meropenem PK in critically ill children, 2) identify factors associated with interindividual PK variability, and 3) evaluate the PK/PD target attainment rates of current and alternative dosing strategies against the most used PK/PD targets. DESIGN: Observational PK study with plasma samples taken after the first and steady state doses after receiving IV meropenem. Data were analyzed using nonlinear mixed-effects modeling. Monte Carlo simulations were performed to evaluate the probability of PK/PD target attainment for different dosing strategies within the first 48 hours of treatment. SETTING: Neonatal and PICU of two Belgian tertiary care hospitals, 2012–2020. PATIENTS: Fifty-four critically ill children (7 d to 14.5 yr old) receiving meropenem infusion at 20–40 mg/kg every 6, 8, or 12 hours. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Four hundred twenty-three plasma samples were used for population PK analysis. A two-compartment model with allometric scaling and a sigmoidal maturation function accounting for the effects of growth and development best described the data. The typical values for clearance, central volume of distribution, intercompartmental clearance, and peripheral volume of distribution were 13.1, 12.5, 23.9 L/hr/70 kg, and 16.3 L/70 kg, respectively. A loading dose of 40 mg/kg, followed by a continuous infusion of 60 mg/kg/d, was required to achieve 100% of the time the unbound concentration above the minimum inhibitory concentration (MIC) against Enterobacterales species and Pseudomonas aeruginosa (MIC ≤ 2 mg/L) without compromising safety. CONCLUSIONS: Standard intermittent dosing regimens (20–40 mg/kg every 8 hr over 0.5 hr) are likely to result in subtherapeutic concentrations, thereby risking therapy failure in critically ill children. A loading dose followed by continuous infusion is suggested for optimal target attainment.Keywords
This publication has 36 references indexed in Scilit:
- From PICU to NICU: Extrapolating Meropenem Exposure From Pediatric to Neonatal Intensive Care PatientsThe Journal of Clinical Pharmacology, 2025
- Scoping review of augmented renal clearance in critically ill pediatric patientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2021
- Approaches to handling missing or “problematic” pharmacology data: PharmacokineticsCPT: Pharmacometrics & Systems Pharmacology, 2021
- A guide to therapeutic drug monitoring of β‐lactam antibioticsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2021
- Population pharmacokinetics of meropenem in critically ill children with different renal functionsEuropean Journal of Clinical Pharmacology, 2019
- Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current LiteratureClinical Pharmacokinetics, 2019
- Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?Pediatric Nephrology, 2018
- Pharmacokinetic/Pharmacodynamic Considerations of Beta-Lactam Antibiotics in Adult Critically Ill PatientsCurrent Infectious Disease Reports, 2018
- Clinical Pharmacology Studies in Critically Ill ChildrenPharmaceutical Research, 2016
- Human renal function maturation: a quantitative description using weight and postmenstrual agePediatric Nephrology, 2009